| scholarly article | Q13442814 |
| P50 | author | Mariann Gyöngyösi | Q63389907 |
| P2093 | author name string | Andreas Spannbauer | |
| Katrin Zlabinger | |||
| Denise Traxler | |||
| Ena Hašimbegović | |||
| Julia Mester-Tonczar | |||
| Nina Kastner | |||
| P2860 | cites work | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis | Q28585453 |
| PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte | Q91410542 | ||
| 3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications | Q91786622 | ||
| Large Animal Models of Heart Failure With Reduced Ejection Fraction (HFrEF) | Q93048686 | ||
| Noncoding RNAs in Vascular Diseases | Q93177853 | ||
| Regulation of cardiac hypertrophy by intracellular signalling pathways | Q29615166 | ||
| Natural RNA circles function as efficient microRNA sponges | Q29617892 | ||
| Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic | Q30250365 | ||
| Non-coding RNAs in cardiac hypertrophy. | Q33800147 | ||
| The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. | Q34278940 | ||
| A long noncoding RNA protects the heart from pathological hypertrophy | Q34287928 | ||
| MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression | Q34396795 | ||
| Chromatin remodeling in cardiovascular development and physiology | Q34814306 | ||
| Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade | Q35549144 | ||
| Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. | Q36512389 | ||
| Cardiac Fibrosis: The Fibroblast Awakens | Q36708340 | ||
| MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress | Q37038566 | ||
| MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 | ||
| Hydrogen (H2) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways | Q37368663 | ||
| The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy | Q37544984 | ||
| Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. | Q38364630 | ||
| 3D culture for cardiac cells. | Q38666755 | ||
| An assessment of norepinephrine mediated hypertrophy to apoptosis transition in cardiac cells: a signal for cell death | Q38936567 | ||
| Disease Modeling in Stem Cell-Derived 3D Organoid Systems. | Q39199665 | ||
| Divergent physiological responses in laboratory rats and mice raised at high altitude | Q41471039 | ||
| Macrophage microRNA-155 promotes cardiac hypertrophy and failure. | Q42250729 | ||
| MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophy | Q42664564 | ||
| The role of microRNA-133 in cardiac hypertrophy uncovered | Q42871326 | ||
| Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system | Q43799989 | ||
| A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy | Q44583245 | ||
| Differences between human and mouse embryonic stem cells | Q45345133 | ||
| CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation | Q46662082 | ||
| Humans in a Dish: The Potential of Organoids in Modeling Immunity and Infectious Diseases | Q47094121 | ||
| AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation | Q48162944 | ||
| Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association | Q49546493 | ||
| Myofilament Calcium-Buffering Dependent Action Potential Triangulation in Human-Induced Pluripotent Stem Cell Model of Hypertrophic Cardiomyopathy | Q49957679 | ||
| A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. | Q50538740 | ||
| MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy. | Q51438500 | ||
| Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. | Q51564269 | ||
| MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes. | Q51598807 | ||
| Engineering an in vitro organotypic model for studying cardiac hypertrophy. | Q51735223 | ||
| Mechanical stretch induced transcriptomic profiles in cardiac myocytes. | Q52651221 | ||
| Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy. | Q55469742 | ||
| Human Cardiac Organoids for Disease Modeling | Q58554619 | ||
| Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review | Q58558029 | ||
| Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation | Q58801788 | ||
| Mechanisms of physiological and pathological cardiac hypertrophy | Q63131766 | ||
| A high-throughput ratiometric method for imaging hypertrophic growth in cultured primary cardiac myocytes | Q64075831 | ||
| The emerging roles and functions of circular RNAs and their generation | Q64089103 | ||
| The G-231A polymorphism in the endothelin-A receptor gene is associated with lower aortic pressure in patients with dilated cardiomyopathy | Q79470543 | ||
| [Cardiac hypertrophy: molecular and cellular events] | Q83914465 | ||
| MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a | Q87070573 | ||
| The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489 | Q87336307 | ||
| MicroRNAs in Cardiac Hypertrophy | Q90233337 | ||
| MicroRNA-29a attenuates angiotensin-II induced-left ventricular remodeling by inhibiting collagen, TGF-β and SMAD2/3 expression | Q90283803 | ||
| A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy | Q90751380 | ||
| The effect of Diazoxide on norepinephrine-induced cardiac hypertrophy, in vitro | Q90804251 | ||
| MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ Porcine Cardiac Progenitor Cells In Vitro | Q91253007 | ||
| Noncoding RNAs in Cardiac Hypertrophy | Q91255776 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | tissue engineering | Q1540285 |
| P304 | page(s) | 1314 | |
| P577 | publication date | 2020-08-21 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | New Insights and Current Approaches in Cardiac Hypertrophy Cell Culture, Tissue Engineering Models, and Novel Pathways Involving Non-Coding RNA | |
| P478 | volume | 11 |
Search more.